Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK
2018 · Rheumatology and Therapy · 105 citations
https://doi.org/10.1007/s40744-018-0112-8
K
Katie Tuckwell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
2.7K
Citations
17
h-index
22
i10-index
Katie Tuckwell is an academic researcher from Regeneron (United States). The author has contributed to research in topics: Vasculitis and related conditions & Coagulation, Bradykinin, Polyphosphates, and Angioedema & Systemic Lupus Erythematosus Research. The author has an h-index of 17, co-authored 43 publications.
Papers by this author
worksHealth-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
2019 · Arthritis Research & Therapy · 45 citations
https://doi.org/10.1186/s13075-019-1837-7
Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
2016 · Atherosclerosis · 23 citations
https://doi.org/10.1016/j.atherosclerosis.2016.10.016
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
2020 · Pharmaceutical Research · 17 citations
https://doi.org/10.1007/s11095-019-2752-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat